Preimplantation Genetic Testing for Aneuploidies

Improves the chances of reproductive success by selecting chromosomally normal embryos

Scroll Down


  • PGT-A (formerly PGS) is a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy).
  • The test is performed on embryos before transfer to the uterus.
  • By analysing all embryos generated in an IVF treatment cycle those free of chromosomal aneuploidy can be selectively transferred.
  • As a result, the pregnancy rates per transfer are significantly increased and the miscarriage rates decreased.


Increases pregnancy rates per transfer

Selecting normal embryos can increase the pregnancy chances after transfer.

Reduction in
miscarriage rate

In the general population, 25% of all clinical pregnancies 
end in miscarriage.

Increase in the likelihood
of having a healthy baby

Some pregnancies with chromosomal anomalies can give rise to the birth of baby with a serious illness.

Reduction in time and necessary resources

The time and resources necessary to achieve a pregnancy are reduced. 

Reduces risk of multiple pregnancy

Helps avoid repeating cycles of assisted reproduction.

According to internal data and several independent clinical studies, selecting normal embryos might increase the pregnancy possibilities after transfer.

Ongoing pregnancy rate PGTA

It is specially useful in cases of advanced maternal age.

In the general population, 25% of all clinical pregnancies end in miscarriage and almost half are chromosomally abnormal.

Therefore, especially in high-risk groups, the PGT-A reduces the risk of misscarriage.

Indice of aneuploid blastocysts according to maternal age

The PGT-A increases the possibility of having a healthy baby, as it allows chromosomally normal embryos to be identified.

The main theoretical time to achieve a LB (weeks) decreases from 14.9 to 7.7 weeks with PGT-A (1)

PGTA cases with at least one normal embryo

PGT-A helps to avoid repeating cycles of assisted reproduction and can help to reduce the number of multiple pregnancies performing single embryo transfer.



  • Advanced maternal age: 35 years or above
  • Recurrent miscarriages: 2 or more miscarriages of unknown cause
  • Assisted reproduction cycles without pregnancy: 2 or more assisted reproduction cycles without pregnancy result
  • Male factor: Males with low sperm concentration, below 5 million per ml
  • Previous pregnancies with anomalies: 1 previous pregnancy with chromosome abnormality, especially in an assisted reproduction cycle


We use the most advanced technology, NGS (Next-Generation Sequencing) to perform the PGT-A test:

  • Ability to detect aneuploidies, mosaicism and segmental alterations
  • Rapid technology allowing embryos to be transferred in fresh or frozen cycles
  • New diagnostic possibilities including the measurement of mitochondrial DNA copy number (MitoScore)
  • Best Cost-effective ratio
  • High flexibility and scalability of the samples

Our technology and experience allows to analyse 24 chromosomes, in a 12-hour procedure which provides results in more than 99% of cases.





Scientific publications and documents.

PGT-A publications

1: Rubio et al: In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.
Fertil Steril. 2017 May;107(5):1122-1129.

2: Rubio et al: Preimplantation genetic screening using fluorescence in situ hybridization inpatients with repetitive implantation failure and advanced maternal age: two randomized trials.
Fertil Steril. 2013 Apr;99(5):1400-7.

3. Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study.
Mol Cytogenet 2012 May 2; 5(1):24.

4. Coates A, Kung A, Mounts E, Hesla J, Bankowski B, Barbieri E, Ata B, Cohen J, Munné S. Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial.
Fertil Steril. 2017 Mar;107(3):723-730.e3.

5. Coates A, Bankowski BJ, Kung A, Griffin DK, Munne S. Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study.
J Assist Reprod Genet. 2017 Jan;34(1):71-78.

Our results

Our experts are professional, reliable and approachable and are available to help guide both professionals and patients throughout the entire process. We are proud to deliver high quality results for every test, every day.


embryos analysed/year


IVF cycles/year


years' experience 
in genetics



Become our provider

Contact us now and we will guide you through the entire process


Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.